about
Rheumatoid arthritis in Latin America: the importance of an early diagnosisAdherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists.Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative.Contrasting diagnosis performance of forced oscillation and spirometry in patients with rheumatoid arthritis and respiratory symptoms.Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study2011 Consensus of the Brazilian Society of Rheumatology for diagnosis and early assessment of rheumatoid arthritis.Critical revision of the medical treatment of gout in Brazil.Brazilian urban population norms derived from the health-related quality of life SF-6D.Prevalence of musculoskeletal symptoms in the five urban regions of Brazil-the Brazilian COPCORD study (BRAZCO).Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated.Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study[Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides].Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis.Guidelines for the drug treatment of rheumatoid arthritis.Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis.Performance of classification criteria for gout in early and established disease.Renal dosing of allopurinol results in suboptimal gout care.Validation of a definition for flare in patients with established gout.Analysis of the association of fatigue with clinical and psychological variables in a series of 371 Brazilian patients with rheumatoid arthritis.Characterization of cumulative joint damage patterns in patients with rheumatoid arthritis: a clinical, serological, and gene polymorphism perspective.Alexander and the Guidelines: the importance of strategy and the guidelines for the diagnosis and medicamentous treatment of rheumatoid arthritis.Study of the frequency of HLA-DRB1 alleles in Brazilian patients with rheumatoid arthritis.Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metricThe International Consortium for Health Outcome Measurement (ICHOM)Set of Outcomes that Matter to People Living with Inflammatory Arthritis Consensus from an international Working GroupOrientações preliminares da Sociedade Brasileira de Reumatologia para avaliação e tratamento da tuberculose infecção latente em pacientes com artrite reumatoide na indisponibilidade do teste tuberculínicoCauses of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohortOpen multicentre clinical trial of diftalone in osteoarthrosisDiagnostic performance of the Forced Oscillation Technique in the detection of early respiratory changes in rheumatoid arthritisThe Long Pentraxin 3 Contributes to Joint Inflammation in Gout by Facilitating the Phagocytosis of Monosodium Urate CrystalsHigh Levels of Polypharmacy in Rheumatoid Arthritis-A Challenge Not Covered by Current Management Recommendations: Data From a Large Real-Life Study
P50
Q26799803-65249E03-216B-4563-8948-AA21CF157DE2Q35746133-4F278A29-F97C-4913-8148-A5BAC641FE0FQ36096803-8D4B090D-68AA-477A-B960-2A6A73D72128Q36223042-5C9E5C6D-7B28-4507-A887-25AB185A8DCDQ37207061-D972E36C-B6DF-4F24-A859-E1E34E5590FAQ37882442-F707B072-57F7-4B41-8A5B-B363EFAE7080Q38661799-4A003C28-C924-4DF7-A880-3DB4D5566BA9Q40274086-607D4203-4E01-4ADF-A3D5-1D46B87F1323Q40279365-4BB161F9-71FB-4614-B159-7D4DC39AF8EDQ40492098-CB91F68E-E3CC-4775-BF27-6B4B0327B1A8Q41079935-C1DC2428-DCBD-4000-A464-E047061DB5F7Q41103987-C24ACC72-F30F-4735-B02B-69D2A4C9733FQ41176187-97F05C78-0461-44BE-813C-57915FA9DDD5Q42319958-67863526-4651-4E77-9630-F42131B27E5AQ43675571-185F7C01-0AB7-4B83-886B-7518B913EA9BQ44537499-815F3206-1710-4A30-9A60-001509A91AAFQ44646610-4A48CAFC-AF25-4FDE-916E-C11879EDB8A5Q46220871-A5FFE732-6582-499D-998E-730975B0EC1FQ47435133-2F6AC434-3F9B-4E9E-9F77-F166771B608FQ47842452-7111BD19-733C-47F3-B96E-141045CEAE23Q50965550-B3451E27-CD63-4A99-A798-F6BF3F0E9DBAQ51797780-45279249-3D67-44D7-97E7-C6265F327BB2Q54346308-BDBDEDA9-A402-4645-8826-446859F07920Q57469543-B02B5EE6-3A62-406A-9301-4567CDA9BFE5Q57789899-F974BFFB-85DC-4266-9CCD-B0E7E718911DQ59243903-5451CA46-66E6-48AE-8739-6C3922A9AA98Q64083868-EA39D4C7-7E8A-4AF7-AA58-3493121DB8E6Q68209624-ADE544FD-1982-4E21-B2D1-800BCE62B1E0Q82550964-3A62A244-F691-4C7D-8882-8F1D7F155F1CQ91339673-4811B3AF-19CD-4A79-978F-702D1F91FEBBQ92878032-79B7D4E3-4596-492C-BE38-56B5031CE960
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Geraldo da Rocha Castelar Pinheiro
@ast
Geraldo da Rocha Castelar Pinheiro
@en
Geraldo da Rocha Castelar Pinheiro
@es
Geraldo da Rocha Castelar Pinheiro
@sl
type
label
Geraldo da Rocha Castelar Pinheiro
@ast
Geraldo da Rocha Castelar Pinheiro
@en
Geraldo da Rocha Castelar Pinheiro
@es
Geraldo da Rocha Castelar Pinheiro
@sl
altLabel
Geraldo da Rocha Castelar Pinheiro
@en
Geraldo da Rocha Castelar-Pinheiro
@en
prefLabel
Geraldo da Rocha Castelar Pinheiro
@ast
Geraldo da Rocha Castelar Pinheiro
@en
Geraldo da Rocha Castelar Pinheiro
@es
Geraldo da Rocha Castelar Pinheiro
@sl
P106
P1153
14527517600
P21
P31
P496
0000-0002-7778-569X